BORDEAUX, France & BOSTON--(BUSINESS WIRE)--Regulatory News:
IMPLANET (Euronext: IMPL, FR0010458729, PEA-PME eligible), a medical technology company specialized in vertebral and knee-surgery implants, today announces publication of a retrospective cost effectiveness study documenting the potential economic benefit of the JAZZ™ Band in scoliosis surgery.
Help employers find you! Check out all the jobs and post your resume.
